Literature DB >> 28689187

Acupuncture for the treatment of gastro-oesophageal reflux disease: a systematic review and meta-analysis.

Jiajie Zhu1,2, Yu Guo2, Shan Liu3, Xiaolan Su2, Yijie Li1, Yang Yang2, Liwei Hou2, Guishu Wang1, Jiaxin Zhang1, Jiande Jd Chen4, Qingguo Wang3, Ruhan Wei5, Wei Wei2.   

Abstract

BACKGROUND: Gastro-oesophageal reflux disease (GORD) is one of the most common diseases presenting to gastroenterology clinics. Acupuncture is widely used as a complementary and alternative treatment for patients with GORD.
OBJECTIVE: To explore the effectiveness of acupuncture for the treatment of GORD.
METHODS: Four English and four Chinese databases were searched through June 2016. Randomised controlled trials investigating the effectiveness of manual acupuncture or electroacupuncture (MA/EA) for GORD versus or as an adjunct to Western medicine (WM) were selected. Data extraction and quality evaluation were performed by two authors independently and RevMan 5.2.0 was used to analyse data.
RESULTS: A total of 12 trials involving 1235 patients were included. Meta-analyses demonstrated that patients receiving MA/EA combined with WM had a superior global symptom improvement compared with those receiving WM alone (relative risk (RR) 1.17, 95% CI 1.09 to 1.26; p=0.03; six studies) with no significant heterogeneity (I2=0%, p=0.41). Recurrence rates of those receiving MA/EA alone were lower than those receiving WM (RR 0.42,95% CI 0.29 to 0.61; p<0.001; three studies) with low heterogeneity (I2=7%, p=0.34), while global symptom improvement (six studies) and symptom scores (three studies) were similar (both p>0.05). Descriptive analyses suggested that acupuncture also improves quality of life in patients with GORD.
CONCLUSION: This meta-analysis suggests that acupuncture is an effective and safe treatment for GORD. However, due to the small sample size and poor methodological quality of the included trials, further studies are required to validate our conclusions. TRIAL REGISTRATION NUMBER: PROSPERO Systematic review registration no. CRD42016041916. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  ACUPUNCTURE; Electroacupuncture; GASTROENTEROLOGY; Gastroenterology

Mesh:

Year:  2017        PMID: 28689187     DOI: 10.1136/acupmed-2016-011205

Source DB:  PubMed          Journal:  Acupunct Med        ISSN: 0964-5284            Impact factor:   2.267


  5 in total

Review 1.  A Methodological and Reporting Quality Assessment of Systematic Reviews/Meta-Analyses about Chinese Medical Treatment for Gastroesophageal Reflux Disease.

Authors:  Zipan Lyu; Zhongyu Huang; Fengbin Liu; Zhengkun Hou
Journal:  Gastroenterol Res Pract       Date:  2020-09-24       Impact factor: 2.260

2.  Validity and reliability of patient section of evidence-based medical records about doctor-patient building through integrated therapy of traditional Chinese and Western medicine (DPEBMR-P) in patients with gastrointestinal diseases.

Authors:  Shuo Feng; Lingxiao Chen; Guihua Tian; Jing Hu; Yang Ding; Zhengguang Du; Hongkai Zhang; Bo Li; Yang Li
Journal:  Ann Transl Med       Date:  2019-03

3.  Acupuncture for refractory gastro-oesophageal reflux disease: a systematic review and meta-analysis protocol.

Authors:  Dacheng Li; Li Zhu; Daming Liu
Journal:  BMJ Open       Date:  2019-08-26       Impact factor: 2.692

4.  Effects of Osteopathic Visceral Treatment in Patients with Gastroesophageal Reflux: A Randomized Controlled Trial.

Authors:  Nuria Eguaras; Elena Sonsoles Rodríguez-López; Olga Lopez-Dicastillo; M Ángeles Franco-Sierra; François Ricard; Ángel Oliva-Pascual-Vaca
Journal:  J Clin Med       Date:  2019-10-19       Impact factor: 4.241

5.  Acupuncture effect on digestion in critically ill postoperative oral and hypopharyngeal cancer patients: A protocol for double-blind randomized control trial.

Authors:  Eyal Ben-Arie; Pei-Yu Kao; Wen-Chao Ho; Yu Chen Lee
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.